Please use this identifier to cite or link to this item: https://hdl.handle.net/10646/2813
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMorton, D.J.-
dc.date.accessioned2016-09-27T12:48:59Z-
dc.date.available2016-09-27T12:48:59Z-
dc.date.issued1986-01-
dc.identifier.citationMorton, D. J. (1986). Comparison of In vitro bioavailability of proprietary propranolol preparations. Central African Journal of Medicine, 32 (1), 23-24.en_US
dc.identifier.issn0008-9176-
dc.identifier.urihttp://hdl.handle.net/10646/2813-
dc.description.abstractDissolution rate studies were conducted to compare the release rate of propranolol from two proprietary preparations. Propranolol was released at a faster rate from Rexigen* when compared to Inderal* which suggests that plasma levels of the drug would be higher in patients taking the former preparation. Both preparations showed satisfactory dissolution but problems may be encountered if a patient stabilized on one brand were to change to the other.en_US
dc.language.isoen_ZWen_US
dc.publisherUniversity of Zimbabwe, College of Health Sciencesen_US
dc.subjectPropranololen_US
dc.subjecthypertensionen_US
dc.subjectcardiac arrhythmiasen_US
dc.titleComparison of In Vitro bioavailability of proprietary propranolol preparationsen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy Staff Publications

Files in This Item:
File Description SizeFormat 
Morton_Comparison_of_In_Vitro_Bioavailability.pdf86.49 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.